Alaunos Therapeutics Inc. (NASDAQ: TCRT) Stock Information | RedChip

Alaunos Therapeutics Inc. (NASDAQ: TCRT) Listen to this Section


$2.45
+0.0299 ( +1.24% ) 9.9K

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

Market Data


Open


$2.45

Previous close


$2.42

Volume


9.9K

Market cap


$3.76M

Day range


$2.36 - $2.49

52 week range


$2.29 - $32.85

Insider Ownership Transactions

Total Amount Purchased: -875,614.00 | $ -2,145,254.30

Date Type Amount Purchased Purchaser
2024-06-10 Sale -12800.00 Hofmeister Robert
2024-06-10 Sale -12800.00 Postma Robert W
2024-06-10 Sale -12800.00 Vieser Jaime
2024-06-10 Sale -19200.00 Weis Holger
2024-01-23 Sale -600000.00 Hogue Dale Curtis Jr.
2024-01-03 Sale -150000.00 Hogue Dale Curtis Jr.
2023-09-05 Sale -68014.00 Boyle Kevin S. Sr.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 40 Aug 14, 2024
8-k/a 8K-related 12 Jul 17, 2024
8-k/a 8K-related 12 Jul 17, 2024
8-k 8K-related 12 Jul 16, 2024
8-k 8K-related 12 Jul 16, 2024
8-k 8K-related 13 Jun 21, 2024
8-k 8K-related 12 Jun 12, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.